Literature DB >> 16820894

Constitutive histone H2AX phosphorylation on Ser-139 in cells untreated by genotoxic agents is cell-cycle phase specific and attenuated by scavenging reactive oxygen species.

Xuan Huang1, Toshiki Tanaka, Akira Kurose, Frank Traganos, Zbigniew Darzynkiewicz.   

Abstract

DNA damage, particularly when it involves formation of double-strand breaks (DSBs), triggers phosphorylation of histone H2AX on Ser-139. Phosphorylated H2AX has been named gammaH2AX, and induction of gammaH2AX in cells exposed to genotoxic agents is considered a sensitive and specific reporter of DNA damage. However, in untreated normal cells as well in the cells of various tumor lines cells, a fraction of histone H2AX molecules remain phosphorylated. In the present study, we observed that the extent of this constitutive H2AX phosphorylation varies depending on the cell type (line) and on cell cycle phase and, in most cell types, S and G(2)/M phase cells exhibit greater levels of H2AX phosphorylation than do cells in the G(1) phase. Furthermore, constitutive H2AX phosphorylation in human pulmonary carcinoma A549, lymphoblastoid TK6, and in normal bronchial epithelial cells was reduced following cell exposure to N-acetyl-L-cysteine, a scavenger of reactive oxygen intermediates; the reduction was most pronounced for G(2)M cells. Growth of A549 cells in the presence of buthionine sulfoximine, an inhibitor of glutathione synthetase, amplified the level of constitutive H2AX phosphorylation in A549 cells. The observed constitutive H2AX phosphorylation may be a reflection of the ongoing DNA damage mediated by reactive oxygen species (ROS) generated by metabolic activity during progression through the cell cycle, leading to formation of DSBs during the S phase. Because cumulative DNA damage in proliferating cells mediated by ROS is considered the key mechanism for cell ageing, the present approach to estimate the degree of attenuation of constitutive H2AX phosphorylation by antioxidants may provide a convenient tool to assess the DNA-protective and possible anti-ageing properties of other agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820894

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  47 in total

1.  Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity.

Authors:  Robert J Kinders; Melinda Hollingshead; Scott Lawrence; Jiuping Ji; Brian Tabb; William M Bonner; Yves Pommier; Larry Rubinstein; Yvonne A Evrard; Ralph E Parchment; Joseph Tomaszewski; James H Doroshow
Journal:  Clin Cancer Res       Date:  2010-10-05       Impact factor: 12.531

Review 2.  Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants.

Authors:  Toshiki Tanaka; H Dorota Halicka; Xuan Huang; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2006-09-01       Impact factor: 4.534

3.  Constitutive histone H2AX phosphorylation and ATM activation are strongly amplified during mitogenic stimulation of lymphocytes.

Authors:  T Tanaka; M Kajstura; H D Halicka; F Traganos; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

Review 4.  Cytometry of ATM activation and histone H2AX phosphorylation to estimate extent of DNA damage induced by exogenous agents.

Authors:  Toshiki Tanaka; Xuan Huang; H Dorota Halicka; Hong Zhao; Frank Traganos; Anthony P Albino; Wei Dai; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2007-09       Impact factor: 4.355

5.  Extent of constitutive histone H2AX phosphorylation on Ser-139 varies in cells with different TP53 status.

Authors:  T Tanaka; A Kurose; X Huang; F Traganos; W Dai; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

6.  DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.

Authors:  Jing An; Yue-Cheng Huang; Qing-Zhi Xu; Li-Jun Zhou; Zeng-Fu Shang; Bo Huang; Yu Wang; Xiao-Dan Liu; De-Chang Wu; Ping-Kun Zhou
Journal:  BMC Mol Biol       Date:  2010-03-06       Impact factor: 2.946

7.  Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases.

Authors:  Jonathan P McNally; Scott H Millen; Vandana Chaturvedi; Nora Lakes; Catherine E Terrell; Eileen E Elfers; Kaitlin R Carroll; Simon P Hogan; Paul R Andreassen; Julie Kanter; Carl E Allen; Michael M Henry; Jay N Greenberg; Stephan Ladisch; Michelle L Hermiston; Michael Joyce; David A Hildeman; Jonathan D Katz; Michael B Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

8.  Cytometric assessment of DNA damage by exogenous and endogenous oxidants reports aging-related processes.

Authors:  Hong Zhao; Toshiki Tanaka; H Dorota Halicka; Frank Traganos; Miroslaw Zarebski; Jurek Dobrucki; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2007-11       Impact factor: 4.355

9.  Neuroprotective effects of rosmarinic acid on ciguatoxin in primary human neurons.

Authors:  N Braidy; A Matin; F Rossi; M Chinain; D Laurent; G J Guillemin
Journal:  Neurotox Res       Date:  2013-10-05       Impact factor: 3.911

10.  Kinetics of the UV-induced DNA damage response in relation to cell cycle phase. Correlation with DNA replication.

Authors:  Hong Zhao; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2010-03       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.